Up‐regulation of miR‐10b‐3p promotes the progression of hepatocellular carcinoma cells via targetingCMTM5

Authors:

Abstract
In this study, we investigated how miR‐10b‐3p regulated the proliferation, migration, invasion in hepatocellular carcinoma (HCC) at both in vitro and in vivo levels.CMTM5was among the differentially expressed genes (data fromTCGA). The expression of miR‐10b‐3p andCMTM5 was detected byqRT‐PCRand Western blot (WB). TargetScan was used to acquire the binding sites. Dual‐luciferase reporter gene assay was used to verify the direct target relationship between miR‐10b‐3p andCMTM5.WBanalysis proved that miR‐10b‐3p suppressedCMTM5expression. Furthermore, proliferation, invasion and migration ofHCCcells were measured byMTTassay, colony formation assay, transwell assay and wound‐healing assay, respectively. Kaplan‐Meier plotter valued the overall survival ofCMTM5. Finally, xenograft assay was also conducted to verify the effects of miR‐10b‐3p/CMTM5axis in vivo. Up‐regulation of miR‐10b‐3p and down‐regulation ofCMTM5were detected inHCCtissues and cell lines.CMTM5was verified as a target gene of miR‐10b‐3p. The overexpression ofCMTM5contributed to the suppression of the proliferative, migratory and invasive abilities ofHCCcells. Moreover, the up‐regulation of miR‐10b‐3p and down‐regulation ofCMTM5were observed to be associated with worse overall survival. Lastly, we have confirmed the carcinogenesis‐related roles of miR‐10b‐3p andCMTM5in vivo. We concluded that the up‐regulation of miR‐10b‐3p promoted the progression ofHCCcells via targetingCMTM5.

This publication has 20 references indexed in Scilit: